Menu
Contact Us
Subscribe
Menu

Medicines Law & Policy

20 POSTS 0 COMMENTS
Medicines Law & Policy brings together legal and policy experts in the field of access to medicines, international law, and public health. We provide policy and legal analysis, best practice models and other information that can be used by governments, non-governmental organisations, product development initiatives, funding agencies, UN agencies and others working to ensure the availability of effective, safe and affordable medicines for all.

Thanks to the European Commission, Biogen can extend Tecfidera monopoly for at least two...

Medicines Law & Policy -

New WHO-UNITAID briefing paper: Improving Access to Covid-19 Treatments

Medicines Law & Policy -

Wrapping up 2022 with some noteworthy medicines, law and policy events

Medicines Law & Policy -

Seven recommendations for sharing intellectual property, know-how and technology – report of Global Expert...

Medicines Law & Policy -

Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact

Medicines Law & Policy -

The US NIH will share technology with WHO to fight the pandemic

Medicines Law & Policy -

A second Covid-19 treatment will now be made available through the Medicines Patent Pool

Medicines Law & Policy -

Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp & Dohme. Others...

Medicines Law & Policy -

Advanced Purchase Agreements for Covid-19 Vaccines: Do they ensure Global Public Good?

Medicines Law & Policy -

US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a...

Medicines Law & Policy -
12Page 1 of 2

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

* indicates required






Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.